Sodium Aescinate
CAS No. 20977-05-3
Sodium Aescinate( —— )
Catalog No. M13308 CAS No. 20977-05-3
Extracted from Aesculus wilsonii;Store the product in sealed,cool and dry condition.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | In Stock |
|
| 10MG | 66 | In Stock |
|
| 25MG | 119 | In Stock |
|
| 50MG | 168 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSodium Aescinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionExtracted from Aesculus wilsonii;Store the product in sealed,cool and dry condition.
-
DescriptionExtracted from Aesculus wilsonii;Store the product in sealed,cool and dry condition.(In Vitro):Sodium aescinate can block signals transiting to downstream molecules AKT, ERK, inhibit the proliferation of breast cancer cell MCF-7 cell apoptosis and induced cell apoptosis by suppressing the activation of SRC.(In Vivo):Sodium aescinate may effectively controls and improves wound healing in diabetic rats via its anti-inflammatory and antioxidant activities.Sodium aescinate treatment can alleviate the symptom of polycystic ovary syndrome (PCOS) in rat model through regulating the PI3K/Akt/GSK3-β pathway.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetHIF/HIF Prolyl-hydroxylase
-
RecptorHIF-1α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number20977-05-3
-
Formula Weight1123.21
-
Molecular FormulaC54H83NaO23
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCC(C(C)OC(=O)C)C(=O)OCC12[C@H]3C[C@@]4(C(=CCC5C4(CCC6C5(CCC([C@]6(C)CO)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)C)C)C1CC([C@@H](C2O)O3)(C)C)C.[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kang J, et al. World J Emerg Med. 2013;4(1):63-8.
molnova catalog
related products
-
ML228
ML228 (ML-228, CID-46742353) is an activator of the hypoxia inducible factor (HIF) pathway with EC50 of 1.4 uM in HIF-1α nuclear translocation assays.
-
Oltipraz
Oltipraz (RP 35972, NSC 347901) is a cancer chemopreventive agent with inhibitory effect on angiogenesis and tumor growth.
-
KCN1
KCN1 (HIF inhibitor KCN1) is a small molecule inhibitor of the HIF-1 pathway, antagonizes HIF transcription in bioassay.
Cart
sales@molnova.com